HighVista Strategies LLC

Position in CYTK — Cytokinetics Inc

CIK 1335325 BOSTON, MA

Position in CYTK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$6,645,075

+$2,779,915 QoQ

Shares Held

78,003

+33.0% QoQ

Ownership

0.056%

of shares outstanding

% of Portfolio

1.52%

of 13F equity value

Holder Rank

#143

of 478 holders

Holding Since

Dec 2020

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HighVista Strategies LLC holds $278,365,756 across 70 Biotechnology names. CYTK ranks #14 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	113,031	$15,062,511
2	RVMD	Revolution Medicines, Inc.	66,983	$12,544,576
3	DFTX	Definium Therapeutics, Inc.	242,884	$11,425,263
4	IMVT	Immunovant, Inc.	277,873	$10,706,446
5	PRAX	Praxis Precision Medicines, Inc.	30,210	$10,114,005
6	RLAY	Relay Therapeutics, Inc.	506,235	$9,471,656
7	PCVX	Vaxcyte, Inc.	149,739	$8,704,328
8	TNGX	Tango Therapeutics, Inc.	260,070	$8,129,788

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,645,075	78,003	+33.0%	Shares	Sole	2026-08-14
2026-03-31	$3,865,160	58,643	-48.8%	Shares	Sole	2026-05-15
2025-12-31	$7,279,396	114,564	-13.8%	Shares	Sole	2026-02-17
2025-09-30	$7,305,832	132,930	+93.6%	Shares	Sole	2025-11-14
2025-06-30	$2,268,262	68,652	+53.4%	Shares	Sole	2025-08-14
2025-03-31	$1,798,462	44,749	+213.8%	Shares	Sole	2025-05-15
2024-12-31	$670,837	14,261	+41.8%	Shares	Sole	2025-02-14
2024-09-30	$530,904	10,055	-86.3%	Shares	Sole	2024-11-14
2022-09-30	$3,544,311	73,154	+8.4%	Shares	Sole	2022-11-14
2022-06-30	$2,652,153	67,502	+2.6%	Shares	Sole	2022-08-15
2022-03-31	$2,420,956	65,769	+86.7%	Shares	Sole	2022-05-16
2021-12-31	$1,605,874	35,232	-25.9%	Shares	Sole	2022-02-14
2020-12-31	$987,465	47,520	—	Shares	Sole	2021-02-16
No filing history on record for this holder in this stock.